The Weight Loss And Obesity Management Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The historical growth trend for the Weight Loss And Obesity Management Global Market Report 2025 shows that the market size has significantly expanded over the years. The market is anticipated to rise from $237.89 billion in 2024 to $258.08 billion in 202
The weight loss and obesity management market is predicted to increase to a value of $354.58 billion in 2029, growing at a compound annual growth rate of 8.3%.
Download Your Free Sample of the 2025 Weight Loss And Obesity Management Market Report and Uncover Key Trends Now!The key drivers in the weight loss and obesity management market are:
• Rising focus on preventive healthcare
• Growing awareness of long-term obesity risks
• Increasing availability of personalized nutrition plans
• Growing demand for medically supervised weight programs
The weight loss and obesity management market covered in this report is segmented –
1) By Product And Services: Drugs, Supplements, Equipment, Services
2) By Category: Prescribed, Over The Counter (OTC)
3) By Age Group: Children, Adults, Geriatric
4) By Distribution Channel: Institutional Sales, Retail Sales
5) By Industry Type: Fitness Centers, Slimming Centers, Consulting Services, Online Weight Loss Programs
The key trends in the weight loss and obesity management market are:
• Advancements in metabolic monitoring technology are transforming the weight loss and obesity management market.
• Innovations in AI-based nutrition planning are becoming a significant trend.
• Developments in wearable fitness technology are expected to shape the future of the market.
• Investment in the research and development of anti-obesity drugs, and digital weight management tools are emerging trends in the market.
Major players in the weight loss and obesity management market are:
• F. Hoffmann-La Roche Ltd.
• Medtronic plc
• Takeda Pharmaceutical Company Limited
• Novo Nordisk A/S
• Boehringer Ingelheim International GmbH
• Olympus Corporation
• Apollo Endosurgery Inc.
• Biocon Limited
• WW International Inc.
• Equinox Holdings Inc.
• Noom Inc.
• Jenny Craig Inc.
• Nutrisystem Inc.
• Virta Health Corp.
• Allurion Technologies Inc.
• Atkins Nutritionals Inc.
• ReShape Lifesciences Inc.
• Nalpropion Pharmaceuticals Inc.
• OptiBiotix Health plc
• PRISTYN CARE
North America was the largest region in the weight loss and obesity management market in 2024